Recruiting Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5) NCT05055635 Conditions Anal Cancer, Anus Diseases, Anus Neoplasms, +12 more Locations Danish Centre for Particle Therapy — Aarhus N, Aarhus, Denmark View Trial Details
Completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer NCT00397384 Conditions Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more Locations Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States View Trial Details
Completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Conditions Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more Locations University of Virginia — Charlottesville, Virginia, United States View Trial Details
Completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 Conditions Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more Locations Ohio State University Medical Center — Columbus, Ohio, United States View Trial Details
Completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction NCT00030498 Conditions Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more Locations Cancer and Leukemia Group B — Chicago, Illinois, United States View Trial Details
